Who is iCAD?

iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.

​ADVANCED CANCER DETECTION SOLUTIONSInnovative Cancer Therapy solutions

Discover the iCAD Virtual Experience

Access the critical information you need, wherever you are, despite the COVID pandemic

​LEARN MORE

iCAD’s Response to COVID-19

Read our response to COVID-19 and learn how our portfolio of solutions supporting cancer detection and therapy continue to offer significant benefits to clinicians, patients and the overall healthcare system.

​READ MORE

Recent News

September 15, 2020
iCAD Announces Compelling Data Supporting Launch of First and Only Commercially Available Technology to Provide Short-Term Breast Cancer Risk Assessment

September 9, 2020
iCAD Hosts Free Virtual Roundtable Event Focusing on Making Informed Decisions for Adopting New AI Solutions and Practical Applications in Healthcare

August 27, 2020
iCAD to Present at the LD Micro 500 Virtual Conference

August 10, 2020
iCAD to Participate in the Guggenheim MedTech Disruptors Summit

August 4, 2020
iCAD Reports Financial Results for Second Quarter and Six Months Ended June 30, 2020

July 20, 2020
iCAD Appoints Jeffrey Sirek as Senior Vice President and General Manager of Xoft

CONNECT

© 2020, iCAD Inc.  All rights reserved.  iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.